vs
Side-by-side financial comparison of Allstate (ALL) and CLOVER HEALTH INVESTMENTS, CORP. (CLOV). Click either name above to swap in a different company.
Allstate is the larger business by last-quarter revenue ($17.3B vs $487.7M, roughly 35.6× CLOVER HEALTH INVESTMENTS, CORP.). Allstate runs the higher net margin — 22.1% vs -10.1%, a 32.2% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 5.1%). Allstate produced more free cash flow last quarter ($2.9B vs $-68.7M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 6.6%).
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. The company operates through Allstate Protection; Protection Services; Allstate Health and Benefits; and Run-off Property-Liability segments. The Allstate Protection segment offers private passenger auto and homeowners insurance; specialty auto products, including motorcycle, trailer, motor home, and off-road vehicle insurance; other personal ...
Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.
ALL vs CLOV — Head-to-Head
Income Statement — Q4 2025 vs Q4 2025
| Metric | | |
|---|---|---|
| Revenue | $17.3B | $487.7M |
| Net Profit | $3.8B | $-49.3M |
| Gross Margin | — | — |
| Operating Margin | — | -10.1% |
| Net Margin | 22.1% | -10.1% |
| Revenue YoY | 5.1% | 44.7% |
| Net Profit YoY | 98.8% | -123.2% |
| EPS (diluted) | $14.24 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $17.3B | $487.7M | ||
| Q3 25 | $17.3B | $496.6M | ||
| Q2 25 | $16.6B | $477.6M | ||
| Q1 25 | $16.5B | $462.3M | ||
| Q4 24 | $16.5B | $337.0M | ||
| Q3 24 | $16.6B | $331.0M | ||
| Q2 24 | $15.7B | $356.3M | ||
| Q1 24 | $15.3B | $346.9M |
| Q4 25 | $3.8B | $-49.3M | ||
| Q3 25 | $3.7B | $-24.4M | ||
| Q2 25 | $2.1B | $-10.6M | ||
| Q1 25 | $595.0M | $-1.3M | ||
| Q4 24 | $1.9B | $-22.1M | ||
| Q3 24 | $1.2B | $-9.2M | ||
| Q2 24 | $331.0M | $7.4M | ||
| Q1 24 | $1.2B | $-19.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 24.5% | ||
| Q2 24 | — | 30.3% | ||
| Q1 24 | — | 23.6% |
| Q4 25 | — | -10.1% | ||
| Q3 25 | — | -4.9% | ||
| Q2 25 | — | -2.2% | ||
| Q1 25 | — | -0.3% | ||
| Q4 24 | — | -6.4% | ||
| Q3 24 | — | -2.7% | ||
| Q2 24 | — | 2.0% | ||
| Q1 24 | — | -6.5% |
| Q4 25 | 22.1% | -10.1% | ||
| Q3 25 | 21.7% | -4.9% | ||
| Q2 25 | 12.7% | -2.2% | ||
| Q1 25 | 3.6% | -0.3% | ||
| Q4 24 | 11.7% | -6.6% | ||
| Q3 24 | 7.2% | -2.8% | ||
| Q2 24 | 2.1% | 2.1% | ||
| Q1 24 | 8.0% | -5.5% |
| Q4 25 | $14.24 | — | ||
| Q3 25 | $13.95 | — | ||
| Q2 25 | $7.76 | — | ||
| Q1 25 | $2.11 | — | ||
| Q4 24 | $7.07 | — | ||
| Q3 24 | $4.33 | — | ||
| Q2 24 | $1.13 | — | ||
| Q1 24 | $4.46 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.9B | $78.3M |
| Total DebtLower is stronger | $7.5B | — |
| Stockholders' EquityBook value | $30.6B | $308.7M |
| Total Assets | $119.8B | $541.0M |
| Debt / EquityLower = less leverage | 0.24× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.9B | $78.3M | ||
| Q3 25 | $8.7B | — | ||
| Q2 25 | $9.6B | — | ||
| Q1 25 | $6.5B | — | ||
| Q4 24 | $4.5B | $194.5M | ||
| Q3 24 | $7.0B | $288.0M | ||
| Q2 24 | $5.3B | $254.8M | ||
| Q1 24 | $4.3B | $208.3M |
| Q4 25 | $7.5B | — | ||
| Q3 25 | $8.1B | — | ||
| Q2 25 | $8.1B | — | ||
| Q1 25 | $8.1B | — | ||
| Q4 24 | $8.1B | — | ||
| Q3 24 | $8.1B | — | ||
| Q2 24 | $8.1B | — | ||
| Q1 24 | $7.9B | — |
| Q4 25 | $30.6B | $308.7M | ||
| Q3 25 | $27.5B | $340.9M | ||
| Q2 25 | $24.0B | $344.2M | ||
| Q1 25 | $22.1B | $336.1M | ||
| Q4 24 | $21.4B | $341.1M | ||
| Q3 24 | $20.9B | $342.2M | ||
| Q2 24 | $18.6B | $324.9M | ||
| Q1 24 | $18.6B | $292.5M |
| Q4 25 | $119.8B | $541.0M | ||
| Q3 25 | $120.4B | $559.7M | ||
| Q2 25 | $115.9B | $575.0M | ||
| Q1 25 | $115.2B | $583.7M | ||
| Q4 24 | $111.6B | $580.7M | ||
| Q3 24 | $113.7B | $653.0M | ||
| Q2 24 | $108.4B | $674.2M | ||
| Q1 24 | $105.2B | $671.8M |
| Q4 25 | 0.24× | — | ||
| Q3 25 | 0.29× | — | ||
| Q2 25 | 0.34× | — | ||
| Q1 25 | 0.37× | — | ||
| Q4 24 | 0.38× | — | ||
| Q3 24 | 0.39× | — | ||
| Q2 24 | 0.43× | — | ||
| Q1 24 | 0.43× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.0B | $-68.2M |
| Free Cash FlowOCF − Capex | $2.9B | $-68.7M |
| FCF MarginFCF / Revenue | 16.7% | -14.1% |
| Capex IntensityCapex / Revenue | 0.5% | 0.1% |
| Cash ConversionOCF / Net Profit | 0.78× | — |
| TTM Free Cash FlowTrailing 4 quarters | $9.9B | $-69.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.0B | $-68.2M | ||
| Q3 25 | $3.3B | $12.1M | ||
| Q2 25 | $1.9B | $5.4M | ||
| Q1 25 | $2.0B | $-16.3M | ||
| Q4 24 | $1.7B | $-85.8M | ||
| Q3 24 | $3.2B | $50.0M | ||
| Q2 24 | $2.4B | $44.8M | ||
| Q1 24 | $1.7B | $25.9M |
| Q4 25 | $2.9B | $-68.7M | ||
| Q3 25 | $3.2B | $11.4M | ||
| Q2 25 | $1.9B | $4.8M | ||
| Q1 25 | $1.9B | $-16.5M | ||
| Q4 24 | $1.7B | $-86.1M | ||
| Q3 24 | $3.1B | $49.6M | ||
| Q2 24 | $2.3B | $44.4M | ||
| Q1 24 | $1.6B | $25.5M |
| Q4 25 | 16.7% | -14.1% | ||
| Q3 25 | 18.8% | 2.3% | ||
| Q2 25 | 11.3% | 1.0% | ||
| Q1 25 | 11.4% | -3.6% | ||
| Q4 24 | 10.0% | -25.6% | ||
| Q3 24 | 18.9% | 15.0% | ||
| Q2 24 | 14.7% | 12.5% | ||
| Q1 24 | 10.6% | 7.3% |
| Q4 25 | 0.5% | 0.1% | ||
| Q3 25 | 0.3% | 0.1% | ||
| Q2 25 | 0.0% | 0.1% | ||
| Q1 25 | 0.6% | 0.0% | ||
| Q4 24 | 0.3% | 0.1% | ||
| Q3 24 | 0.4% | 0.1% | ||
| Q2 24 | 0.4% | 0.1% | ||
| Q1 24 | 0.3% | 0.1% |
| Q4 25 | 0.78× | — | ||
| Q3 25 | 0.88× | — | ||
| Q2 25 | 0.89× | — | ||
| Q1 25 | 3.30× | — | ||
| Q4 24 | 0.88× | — | ||
| Q3 24 | 2.69× | — | ||
| Q2 24 | 7.13× | 6.04× | ||
| Q1 24 | 1.37× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
